Methyltransferase-like 3 (METTL3) Epigenetically Modulates Glutathione Peroxidase 4 (GPX4) Expression to Affect Asthma
Asthma, a prevalent chronic airway inflammatory condition, poses a significant health challenge. In this study, we delved into the regulatory mechanisms governing asthma, focusing on Methyltransferase-like 3 (METTL3). Through an ovalbumin (OVA)-induced mouse model and interleukin-13 (IL-13)-induced cell model, we mimicked the in vivo and in vitro functions of METTL3 in asthma. Our research revealed that METTL3 expression significantly decreased in asthma-induced mice and IL-13-stimulated cells compared to the control group. Moreover, METTL3 overexpression enhanced bronchial epithelial cell viability and proliferation. Mechanistically, we observed elevated levels of total iron, Fe2+, malondialdehyde (MDA), lipid reactive oxygen species (ROS), alongside reduced glutathione (GSH) levels in IL-13-stimulated cells. Remarkably, METTL3 overexpression counteracted these effects, suggesting a pivotal role in mitigating asthma-related oxidative stress. Furthermore, our study highlighted the involvement of N6-methyladenosine methylation (m6A) modification, where METTL3 regulated the m6A modification of glutathione peroxidase 4 (GPX4) RNA, impacting RNA stability. Knockdown of METTL3 suppressed m6A modification on GPX4 RNA, impairing its stability and contributing to IL-13-induced ferroptosis. Interestingly, METTL3 overexpression not only inhibited cell ferroptosis but also alleviated asthma symptoms. Our findings shed light on the epigenetic regulation of asthma through METTL3-mediated m6A modification, offering potential therapeutic avenues for this prevalent inflammatory disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Iranian journal of allergy, asthma, and immunology - 22(2023), 6 vom: 28. Dez., Seite 551-560 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lin, Liangfeng [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.03.2024 Date Revised 14.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.18502/ijaai.v22i6.14644 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369676688 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369676688 | ||
003 | DE-627 | ||
005 | 20240315000042.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240313s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.18502/ijaai.v22i6.14644 |2 doi | |
028 | 5 | 2 | |a pubmed24n1329.xml |
035 | |a (DE-627)NLM369676688 | ||
035 | |a (NLM)38477952 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lin, Liangfeng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Methyltransferase-like 3 (METTL3) Epigenetically Modulates Glutathione Peroxidase 4 (GPX4) Expression to Affect Asthma |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.03.2024 | ||
500 | |a Date Revised 14.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Asthma, a prevalent chronic airway inflammatory condition, poses a significant health challenge. In this study, we delved into the regulatory mechanisms governing asthma, focusing on Methyltransferase-like 3 (METTL3). Through an ovalbumin (OVA)-induced mouse model and interleukin-13 (IL-13)-induced cell model, we mimicked the in vivo and in vitro functions of METTL3 in asthma. Our research revealed that METTL3 expression significantly decreased in asthma-induced mice and IL-13-stimulated cells compared to the control group. Moreover, METTL3 overexpression enhanced bronchial epithelial cell viability and proliferation. Mechanistically, we observed elevated levels of total iron, Fe2+, malondialdehyde (MDA), lipid reactive oxygen species (ROS), alongside reduced glutathione (GSH) levels in IL-13-stimulated cells. Remarkably, METTL3 overexpression counteracted these effects, suggesting a pivotal role in mitigating asthma-related oxidative stress. Furthermore, our study highlighted the involvement of N6-methyladenosine methylation (m6A) modification, where METTL3 regulated the m6A modification of glutathione peroxidase 4 (GPX4) RNA, impacting RNA stability. Knockdown of METTL3 suppressed m6A modification on GPX4 RNA, impairing its stability and contributing to IL-13-induced ferroptosis. Interestingly, METTL3 overexpression not only inhibited cell ferroptosis but also alleviated asthma symptoms. Our findings shed light on the epigenetic regulation of asthma through METTL3-mediated m6A modification, offering potential therapeutic avenues for this prevalent inflammatory disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Asthma | |
650 | 4 | |a Bronchial disease | |
650 | 4 | |a Epithelial cells | |
650 | 4 | |a Ferroptosis | |
650 | 4 | |a Glutathione peroxidase 4 | |
650 | 4 | |a METTL3 protein, human | |
650 | 4 | |a Oxidative stress | |
650 | 4 | |a RNA stability | |
650 | 7 | |a Interleukin-13 |2 NLM | |
650 | 7 | |a Methyltransferases |2 NLM | |
650 | 7 | |a EC 2.1.1.- |2 NLM | |
650 | 7 | |a Phospholipid Hydroperoxide Glutathione Peroxidase |2 NLM | |
650 | 7 | |a EC 1.11.1.12 |2 NLM | |
650 | 7 | |a RNA |2 NLM | |
650 | 7 | |a 63231-63-0 |2 NLM | |
650 | 7 | |a glutathione peroxidase 4, mouse |2 NLM | |
650 | 7 | |a EC 1.11.1.9 |2 NLM | |
650 | 7 | |a Mettl3 protein, mouse |2 NLM | |
650 | 7 | |a EC 2.1.1.- |2 NLM | |
700 | 1 | |a Hu, Xiaohao |e verfasserin |4 aut | |
700 | 1 | |a Li, Qiaoyu |e verfasserin |4 aut | |
700 | 1 | |a Huang, Linlin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Iranian journal of allergy, asthma, and immunology |d 2003 |g 22(2023), 6 vom: 28. Dez., Seite 551-560 |w (DE-627)NLM167826980 |x 1735-5249 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2023 |g number:6 |g day:28 |g month:12 |g pages:551-560 |
856 | 4 | 0 | |u http://dx.doi.org/10.18502/ijaai.v22i6.14644 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2023 |e 6 |b 28 |c 12 |h 551-560 |